There's still a month and half of the CY to run Lastly ,
In July there was additional confirmation from the BOD in an Official ASX Announcement
Corporate outcome targeted CY23 on the licensing or sale of MPL’s vet cancer applications
following commercially valuable Phase 2 outcomes
The K9 Cancer Commercial Outcome is the strategy to fund moving forward with Human Cancer and future trialing , this was promoted as it would negate further SH dilution and nullify the necessity of future CR's...
I'm only going by what Roger and the Board have published to the markets...NZT
Best of Luck to MT and PI Mathers , feel sure they will receive a warm welcome from the MND Community.....
Ann: PharmAust to present at Emerging ASX Gems Conference, page-82
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $60.84K | 317.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 120380 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 22618 | 3 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |